Literature DB >> 7921228

Molecular characterization of a cloned human oxytocin receptor.

T Kimura1, Y Makino, F Saji, M Takemura, T Inoue, T Kikuchi, Y Kubota, C Azuma, T Nobunaga, Y Tokugawa.   

Abstract

We describe here the binding and functional properties of a cloned human oxytocin receptor (OTR). We established a transient OTR expression system on COS-1 cells, which do not express vasopressin receptors. With the transfected cells and [3H]oxytocin, the dissociation constant (Kd) of OTR to oxytocin was 6.0 +/- 1.1 nmol/l; the binding properties of several oxytocin-related peptides were also examined. The functional properties of OTR were determined by an electrophysiological method, using a Xenopus laevis oocyte injected with in vitro transcribed OTR mRNA. These two methods showed that [Phe2,Orn8]vasotocin, a vasopressin agonist, was an OTR antagonist. A combination of these methods using cloned OTR cDNA is a novel and effective method for the investigation of oxytocin-related ligands.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921228     DOI: 10.1530/eje.0.1310385

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  18 in total

1.  Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.

Authors:  A Tahara; J Tsukada; Y Tomura; K i Wada; T Kusayama; N Ishii; T Yatsu; W Uchida; A Tanaka
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 2.  Chemotherapeutic induction of labour. A rational approach.

Authors:  E M Xenakis; J M Piper
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 3.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 4.  Oxytocin and social motivation.

Authors:  Ilanit Gordon; Carina Martin; Ruth Feldman; James F Leckman
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.

Authors:  Christian W Gruber; Markus Muttenthaler; Michael Freissmuth
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

7.  Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.

Authors:  Renee R Handley; Suzanne J Reid; Rudiger Brauning; Paul Maclean; Emily R Mears; Imche Fourie; Stefano Patassini; Garth J S Cooper; Skye R Rudiger; Clive J McLaughlan; Paul J Verma; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

8.  Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice.

Authors:  Yuki Takayanagi; Masahide Yoshida; Isadora F Bielsky; Heather E Ross; Masaki Kawamata; Tatsushi Onaka; Teruyuki Yanagisawa; Tadashi Kimura; Martin M Matzuk; Larry J Young; Katsuhiko Nishimori
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

9.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

10.  Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates.

Authors:  Maria L Boccia; Anne-Pierre S Goursaud; Jocelyne Bachevalier; Kenneth D Anderson; Cort A Pedersen
Journal:  Horm Behav       Date:  2007-05-21       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.